A systematic review to assess the policy-making relevance of dementia cost-of-illness studies in the US and Canada

PharmacoEconomics

Volumn 29, Issue 2, 2011, Pages 141-156

  Oremus, Mark ^a   Aguilar, S Carolina ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b Canadian Researchers at the End of Life Network (CARENET)   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; CANADA; CAREGIVER; COMPARATIVE STUDY; COST OF ILLNESS; DEMENTIA; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HUMAN; MEDICAID; MEDICAL RESEARCH; MEDICARE; PRIORITY JOURNAL; REVIEW; SOCIAL WORK; SYSTEMATIC REVIEW; UNITED STATES;

ALZHEIMER DISEASE; CANADA; CLINICAL TRIALS AS TOPIC; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DEMENTIA; HUMANS; POLICY MAKING; UNITED STATES;

EID: 78751637139     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11539450-000000000-00000     Document Type: Review

References (62)

1. Kester MI, Scheltens P. Dementia: the bare essentials. Pract Neurol 2009; 9: 241-51
2. Wolfson C, Wolfson DB, Asgharian M, et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 2001; 344: 1111-6
3. Jonsson L, Wimo A. The cost of dementia in Europe: a review of the evidence, and methodological considerations. Pharmacoeconomics 2009; 27 (5): 391-403
4. Rice DP, Fillit HM, Max W, et al. Prevalence, costs, and treatment of Alzheimers disease and related dementia: a managed care perspective. Am J Manag Care 2001; 7: 809-18
5. Bloom BS, de Pouvourville N, Straus WL, et al. Cost of illness of Alzheimers disease: how useful are current estimates? Gerontologist 2003; 43: 158-64
6. Jonsson L, Berr C. Cost of dementia in Europe. Eur J Neurol 2005; 12 Suppl. 1: 50-3
7. Byford S, Torgerson DJ, Raftery J. Economic note: cost of illness studies. BMJ 2000 May 13; 320 (7245): 1335
8. Patton MQ. Qualitative research and evaluation methods. 3rd rev. Thousand Oaks (CA): Sage Publications, 2002
9. US Bureau of Labor Statistics. CPI inflation calculator. Washington, DC: US Bureau of Labor Statistics [online]. Available from URL: http://www.bls.gov/ data/inflation-calculator.htm [Accessed 2010 Jun 7]
10. OANDA.com. FX history: historical currency conversion rates. New York:OANDA Corporation [online]. Available from URL: http://www.oanda.com/ convert/fxhistory [Accessed 2010 Jun 7]
11. Kane RL, Atherly A. Medicare expenditures associated with Alzheimer disease. Alzheimer Dis Assoc Disord 2000; 14: 187-95
12. OBrien JA, Caro JJ. Alzheimers disease and other dementia in nursing homes: levels of management and cost. Int Psychogeriatr 2001; 13: 347-58
13. Rice D, Fox PJ, Max W, et al. The economic burden of Alzheimers disease care. Health Aff (Millwood) 1993; 12: 164-76
14. Max W, Webber P, Fox P. Alzheimer disease: the unpaid burden of caring. J Aging Health 1995; 7: 179-99
15. Stern Y, Folstein M, Albert M, et al. Multicenter study of predictors of disease course in Alzheimer disease (the predictors study): I. Study design, cohort description, and intersite comparisons. Alzheimer Dis Assoc Disord 1993; 7: 3-21 (Pubitemid 23127936)
16. Zhu CW, Scarmeas N, Torgan R, et al. Clinical features associated with costs in early AD: baseline data from the Predictors Study. Neurology 2006; 66: 1021-8
17. Zhu CW, Scarmeas N, Torgan R, et al. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology 2006; 67: 998-1005
18. Zhu CW, Scarmeas N, Torgan R, et al. Clinical characteristics and longitudinal changes of informal cost of Alzheimers disease in the community. J Am Geriatr Soc 2006; 54: 1596-602
19. Zhu CW, Leibman C, McLaughlin T, et al. The effects of patient function and dependence on costs of care in Alzheimers disease. J Am Geriatr Soc 2008; 56: 1497-503
20. Zhu CW, Leibman C, McLaughlin T, et al. Patient dependence and longitudinal changes in costs of care in Alzheimers disease. Dement Geriatr Cogn Disord 2008; 26: 416-23
21. Stern Y, Albert SM, Sano M, et al. Assessing patient dependence in Alzheimers disease. J Gerontol 1994; 49: M216-22
22. Blessed G, Tomlinson BE, RothM. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114: 797-811
23. Zhu CW, Scarmeas N, Stavitsky K, et al. Comparison of costs of care between patients with Alzheimers disease and dementia with Lewy bodies. Alzheimers Dement 2008; 4: 280-4
24. Hanson JC, Lippa CF. Lewy body dementia. Int Rev Neurobiol 2009; 84: 215-28
25. No authors listed. Costs: measuring the economic burden of Alzheimers disease care. J Nurs Adm 1997; 27 (1): 4-8
26. Albert SM, Glied S, Andrews H, et al. Primary care expenditures before the onset of Alzheimers disease. Neurology 2002; 59: 573-8
27. Bynum JP, Rabins PV, Weller W, et al. The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use. J Am Geriatr Soc 2004; 52: 187-94
28. Ernst RL, Hay JW. The US economic and social costs of Alzheimers disease revisited. Am J Public Health 1994; 84: 1261-4
29. Ernst RL, Hay JW, Fenn C, et al. Cognitive function and the costs of Alzheimer disease: an exploratory study. Arch Neurol 1997; 54: 687-93
30. Fillenbaum G, Heyman A, Peterson BL, et al. Use and cost of hospitalization of patients with AD by stage and living arrangement: CERAD XXI. Neurology 2001; 56: 201-6
31. Fillit H, Hill JW, Futterman R. Health care utilization and costs of Alzheimers disease: the role of co-morbid conditions, disease stage, and pharmacotherapy. FamMed 2002; 34: 528-35
32. Fillit H, Hill J. The costs of vascular dementia: a comparison with Alzheimers disease. J Neurol Sci 2002 Nov 15; 203- 204: 35-9
33. Fox PJ, Kohatsu N, Max W, et al. Estimating the costs of caring for people with Alzheimer disease in California: 2000-2040. J Public Health Policy 2001; 22: 88-97
34. Frytak JR, Henk HJ, Zhao Y, et al. Health service utilization among Alzheimers disease patients: evidence from managed care. Alzheimers Dement 2008; 4: 361-7
35. Gutterman EM, Markowitz JS, Lewis B, et al. Cost of Alzheimers disease and related dementia in managed-Medicare. J Am Geriatr Soc 1999; 47: 1065-71
36. Harrow BS, Mahoney DF, Mendelsohn AB, et al. Variation in cost of informal caregiving and formal-service use for people with Alzheimers disease. Am J Alzheimers Dis Other Demen 2004; 19: 299-308
37. Hay JW, Ernst RL. The economic costs of Alzheimers disease. Am J Public Health 1987; 77: 1169-75
38. Herrmann N, Lanctot KL, Sambrook R, et al. The contribution of neuropsychiatric symptoms to the cost of dementia care. Int J Geriatr Psychiatry 2006; 21: 972-6
39. Hu TW, Huang LF, CartwrightWS. Evaluation of the costs of caring for the senile demented elderly: a pilot study. Gerontologist 1986; 26: 158-63
40. Huang LF, Cartwright WS, Hu TW. The economic cost of senile dementia in the United States, 1985. Public Health Rep 1988; 103: 3-7
41. Hux MJ, OBrien BJ, Iskedjian M, et al. Relation between severity of Alzheimers disease and costs of caring. CMAJ 1998; 159: 457-65
42. Kuo TC, Zhao Y,Weir S, et al. Implications of comorbidity on costs for patients with Alzheimer disease. Med Care 2008; 46: 839-46
43. Lamb CE, Ratner PH, Johnson CE, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin 2006; 22: 1203-10
44. Langa KM, Chernew ME, Kabeto MU, et al. National estimates of the quantity and cost of informal caregiving for the elderly with dementia. J Gen Intern Med 2001; 16: 770-8
45. Leon J, Cheng CK, Neumann PJ. Alzheimers disease care: costs and potential savings. Health Aff (Millwood) 1998; 17: 206-16
46. Leon J, Neumann PJ. The cost of Alzheimers disease in managed care: a cross-sectional study. Am J Manag Care 1999; 5: 867-77
47. Martin BC, Ricci JF, Kotzan JA, et al. The net cost of Alzheimer disease and related dementia: a population-based study of Georgia Medicaid recipients. Alzheimer Dis Assoc Disord 2000; 14: 151-9
48. McCormick WC, Hardy J, Kukull WA, et al. Healthcare utilization and costs in managed care patients with Alzheimers disease during the last few years of life. J Am Geriatr Soc 2001; 49: 1156-60
49. Menzin J, Lang K, Friedman M, et al. The economic cost of Alzheimers disease and related dementias to the California Medicaid program (Medi-Cal) in 1995. Am J Geriatr Psychiatry 1999; 7: 300-8
50. Moore MJ, Zhu CW, Clipp EC. Informal costs of dementia care: estimates from the National Longitudinal Caregiver Study. J Gerontol B Psychol Sci Soc Sci 2001; 56: S219-28
51. Ostbye T, Crosse E. Net economic costs of dementia in Canada. CMAJ 1994; 151: 1457-64
52. Sloan FA, Taylor Jr DH. Effect of Alzheimer disease on the cost of treating other diseases. Alzheimer Dis Assoc Disord 2002; 16: 137-43
53. Small GW, McDonnell DD, Brooks RL, et al. The impact of symptom severity on the cost of Alzheimers disease. J Am Geriatr Soc 2002; 50: 321-7
54. Stommel M, Collins CE, Given BA. The costs of family contributions to the care of persons with dementia. Gerontologist 1994; 34: 199-205
55. Stuart B, Gruber-Baldini AL, Fahlman C, et al. Medicare cost differences between nursing home patients admitted with and without dementia. Gerontologist 2005; 45: 505-15
56. Taylor Jr DH, Sloan FA. How much do persons with Alzheimers disease cost Medicare? J Am Geriatr Soc 2000; 48: 639-46
57. Taylor Jr DH, Schenkman M, Zhou J, et al. The relative effect of Alzheimers disease and related dementias, disability, and comorbidities on cost of care for elderly persons. J Gerontol B Psychol Sci Soc Sci 2001; 56: S285-93
58. Welch HG, Walsh JS, Larson EB. The cost of institutional care in Alzheimers disease: nursing home and hospital use in a prospective cohort. J Am Geriatr Soc 1992; 40: 221-4
59. Zhao Y, Kuo TC, Weir S, et al. Healthcare costs and utilization for Medicare beneficiaries with Alzheimers. BMC Health Serv Res 2008 May 22; 8: 108
60. Zimmerman S, Gruber-Baldini AL, Hebel JR, et al. Nursing home characteristics related to medicare costs for residents with and without dementia. Am J Alzheimers Dis Other Demen 2008; 23: 57-65
61. Raina P, Santaguida P, Ismaila A, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Int Med 2008; 148: 379-85
62. Wimo A. The art of cost of illness. J AlzheimersDis 2010; 19: 617-9